COVID-19 vaccine trials with children: ethics pointers

Area of Science:

• Medical Ethics
• Pediatric Clinical Trials
• Global Health

Background:

• Global vaccination efforts for SARS-CoV-2 (the virus causing COVID-19) now include children.
• Clinical trials in children are essential for establishing safety, efficacy, and appropriate dosages.
• Ethical review of pediatric COVID-19 vaccine trials in low- and middle-income countries (LMICs) presents unique challenges.

Purpose of the Study:

• To identify and address key ethical questions for phase III COVID-19 vaccine trials involving children in resource-limited settings.
• To provide considerations for ethics committees and policymakers reviewing these trials.

Main Methods:

• The study outlines critical ethical questions relevant to pediatric COVID-19 vaccine trials.
• It discusses issues such as vaccine relevance, use of unapproved vaccines in trials, participant selection, informed consent for minors, placebo use, and ancillary care obligations.

Main Results:

• Key ethical considerations include the relevance of the trial vaccine to the local population.
• Decisions regarding the use of vaccines not yet approved for adults in pediatric trials require careful ethical scrutiny.
• Informed consent processes for minors and the provision of ancillary care are critical, particularly in LMICs.

Conclusions:

• Implementing COVID-19 vaccine trials in children in LMICs necessitates careful ethical deliberation.
• Addressing specific ethical questions proactively ensures participant welfare and the integrity of research in diverse global settings.